Home LiteratureArticle Details
PMID: 10228022 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Multiple roles for IL-12 in a model of acute septic peritonitis.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 162 ·No. 9 ·1999-05-01 ·Pages 5437-43

Steinhauser ML, Hogaboam CM, Lukacs NW, Strieter RM, Kunkel SL

Abstract

The present study addressed the role of IL-12 in a murine model of septic peritonitis, induced by cecal ligation and puncture (CLP). Although CLP surgery induced IL-12 production at 6 and 24 h after surgery, IL-12 immunoneutralization was clearly deleterious in this model: 54% of CLP mice receiving preimmune serum survived, whereas mice administered IL-12 antisera prior to CLP experienced a 25% survival rate. IL-12 immunoneutralization not only led to increased mortality, but also appeared to promote a shift away from IL-12 and IFN-gamma, in favor of IL-10. This cytokine shift corresponded to changes in bacterial load, as CLP mice receiving IL-12 antiserum yielded more CFUs from the peritoneal cavity at 24 h after CLP. To address the role of bacterial infection in IL-12 antiserum-induced mortality following CLP, antibiotics were administered for 4 days after surgery. Despite regular antibiotic administration, IL-12 immunoneutralization still reduced survival in CLP mice. Furthermore, histology of the ceca revealed that mice administered IL-12 antisera failed to show typical organization of the damaged cecum wall. Accordingly, Gram staining revealed bacteria within peritoneal fluids from these mice, while peritoneal fluids from CLP mice that received preimmune serum and antibiotics were free of bacteria. Altogether, these data suggested multiple important roles for IL-12 in the evolution of murine septic peritonitis.

MeSH Terms
Acute Disease Animals Cecal Diseases/immunology,microbiology Cilastatin/therapeutic use Cilastatin, Imipenem Drug Combination Disease Models, Animal Drug Combinations Drug Therapy, Combination/therapeutic use Female Fibrosis Imipenem/therapeutic use Immune Sera/administration & dosage Immunization, Passive Interferon-gamma/antagonists & inhibitors,biosynthesis Interleukin-10/biosynthesis Interleukin-12/antagonists & inhibitors,biosynthesis,immunology,physiology Intestinal Perforation/immunology,microbiology Ligation Mice Peritoneum/microbiology Peritonitis/drug therapy,immunology,microbiology,mortality Sepsis/drug therapy,immunology,microbiology,mortality Wound Healing/immunology
Chemicals
Drug Combinations Immune Sera Interleukin-10 Cilastatin Interleukin-12 Imipenem Interferon-gamma Cilastatin, Imipenem Drug Combination
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Steinhauser M L
Department of Pathology, Division of Pulmonary and Critical Care, University of Michigan Medical School, Ann Arbor 48109, USA.
Hogaboam C M
Lukacs N W
Strieter R M
Kunkel S L
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
1999-05-01
Pages
5437-43
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NHLBI NIH HHS · 1P50HL56402 · United States
NHLBI NIH HHS · HL31963 · United States
NHLBI NIH HHS · HL35276 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]